Nelson Advisors to Chair the panel on the 'European HealthTech Investment Landscape' at HealthTechX on 5th November 2025

HealthTechX 2025
 
The HealthTechX 2025 Summit is a one-day event taking place on November 5, 2025, at The Hurlingham Club in London. It's a key gathering for leaders in the health technology sector, including CEOs, founders, investors, and policymakers.
  
Agenda and Key Themes

The summit's agenda focuses on how technology is transforming healthcare with a tangible impact. Confirmed session topics include:
  
AI-driven diagnostics: Exploring the latest advancements and applications of artificial intelligence in medical diagnosis.

The healthcare workforce gap: Discussing how technology can help address the shortage of healthcare professionals.

Medical robotics: Showcasing innovations in robotics and their role in improving patient care and surgical procedures.

Specific confirmed sessions for the 2025 event include:
 
Beyond the Hype - AI's Place in Healthcare

The Evolution of Telehealth in a Post-COVID World

Hospital to Home - Enabling the Continuum of Care

From Prescription to Prevention - The Challenge of Lifestyle Change

Mental Health and Prevention

Hearing from the Investors

Speakers and Attendees

The event brings together leaders from across the health technology ecosystem. Past and confirmed speakers represent a wide range of organizations, from pharmaceutical and tech giants to innovative startups and investment firms. Attendees can expect to network with individuals from companies such as Merck, IBM, Philips, Takeda, Roche, and AstraZeneca.

https://impactx2050.com/healthtechx

Nelson Advisors HealthTechX 2025

International Investors and European HealthTech' panel

European HealthTech remains undervalued, creating unique openings for overseas investors. This session highlights success stories and the cultural, regulatory and strategic differences to watch.

Nelson Advisors Partner Lloyd Price will Chair the panel discussing the European HealthTech Investment Landscape, covering key questions such as:

Overall Market and Investment Trends

What is the current state of capital flow? Is investment continuing to be concentrated in a few mega-deals, or is there a resurgence in early-stage funding activity?

How are macroeconomic factors impacting the market? How are rising interest rates and inflation affecting deal valuations, investor confidence, and the availability of capital?

What is the investor sentiment towards European HealthTech compared to other global markets like the US or Asia? Is Europe closing the funding gap, and what are its unique strengths?

Which countries or regions in Europe are emerging as HealthTech hubs? Beyond the traditional powerhouses like the UK, Germany, and France, are there new centers of innovation, particularly in Central and Eastern Europe (CEE)?
  
Exits and M&A
  
What is the current state of the exit market? With a subdued IPO market, is M&A the primary exit strategy for HealthTech startups?

Who are the most active acquirers? Are exits driven primarily by strategic buyers (e.g., large pharma, medical device companies) or by private equity firms looking to consolidate the market?

What deal structures are becoming more common in M&A? Are buyers offering more earn-outs, royalties, or joint ventures to share risk and manage high valuations?

To discuss how Nelson Advisors can speak on a panel, chair the discussions or attend  your MedTech or HealthTech event, please email [email protected]